Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Preferred Shares (2022 - 2026)

HeartSciences' Preferred Shares history spans 5 years, with the latest figure at $537.0 for Q1 2026.

  • For Q1 2026, Preferred Shares rose 41.32% year-over-year to $537.0; the TTM value through Jan 2026 reached $537.0, up 41.32%, while the annual FY2025 figure was $380.0, 0.0% changed from the prior year.
  • Preferred Shares reached $537.0 in Q1 2026 per HSCS's latest filing, down from $580.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $580.0 in Q4 2025 to a low of $380.0 in Q3 2023.
  • Average Preferred Shares over 5 years is $416.88, with a median of $380.5 recorded in 2023.
  • Peak YoY movement for Preferred Shares: dropped 21.12% in 2023, then soared 52.63% in 2025.
  • A 5-year view of Preferred Shares shows it stood at $403.0 in 2022, then fell by 5.71% to $380.0 in 2023, then changed by 0.0% to $380.0 in 2024, then skyrocketed by 52.63% to $580.0 in 2025, then dropped by 7.41% to $537.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Preferred Shares are $537.0 (Q1 2026), $580.0 (Q4 2025), and $430.0 (Q3 2025).